Institut Mérieux

Overview

Institut Mérieux is a French family holding company specializing in healthcare investments through its subsidiary, Mérieux Equity Partners. The company focuses on private equity and venture capital investments in the healthcare sector, targeting companies at various stages from seed to buyout. Geographically, Institut Mérieux has a broad investment focus, including countries such as France, the United States, the United Kingdom, Germany, Italy, Spain, the Netherlands, Belgium, Switzerland, Canada, China, Japan, India, Brazil, Australia, South Korea, Mexico, South Africa, Russia, and Turkey. The industries of interest encompass healthcare, biotechnology, pharmaceuticals, diagnostics, immunotherapy, food safety, nutrition, medical devices, medical research, public health, clinical research, laboratory services, health technology, medical equipment, health services, medical supplies, health education, health consulting, health policy, and health advocacy. Investment sizes typically range from €20 million to €80 million per company. Institut Mérieux's investment strategy is to support companies with ambitious growth projects and transformative products or services in the health sector. The firm operates through two dedicated platforms: Innovation and Buyout. The Innovation platform supports the development of innovative medical solutions, from seed to Series B, with investments per company ranging from €3 million to €15 million. The Buyout platform invests in profitable and fast-growing companies to support their projects and development, with investments per company ranging from €20 million to €80 million, potentially more with co-investment. Both platforms focus on minority and majority ownership, respectively, and operate primarily in Europe. Institut Mérieux has a longstanding history in the healthcare sector, with its origins dating back to 1897 when Marcel Mérieux founded the Institut Biologique Mérieux. Over the years, the Mérieux family has established and developed several companies in the fields of human and veterinary vaccines, in vitro diagnostics, immunotherapy, food safety, and nutrition. Today, Institut Mérieux continues to contribute to public health through its various subsidiaries and investments, aiming to improve medicine and public health globally.

Investment Focus

• Innovative medical solutions
• Strong growth potential
• Alignment with healthcare and nutrition sectors
• International expansion capability
• Experienced management teams

Portfolio Companies